A long-term survival analysis of prediagnostic body mass index, plasma C-peptide concentration, and prostate cancer-specific mortality among men with prostate cancer

Ma, JingLi, HaojieGiovannucci, EdMucci, LoreleiQiu, WeiliangNguyen, Paul L.Gaziano, J. MichaelPollak, MichaelStampfer, Meir2019-09-062008Ma, Jing, Haojie Li, Ed Giovannucci, Lorelei Mucci, Weiliang Qiu, Paul L Nguyen, J Michael Gaziano, Michael Pollak, and Meir J Stampfer. 2008. “Prediagnostic Body-Mass Index, Plasma C-Peptide Concentration, and Prostate Cancer-Specific Mortality in Men with Prostate Cancer: A Long-Term Survival Analysis.” The Lancet Oncology 9 (11): 1039–47. https://doi.org/10.1016/s1470-2045(08)70235-3.1470-20451474-5488http://nrs.harvard.edu/urn-3:HUL.InstRepos:41292888en-USA long-term survival analysis of prediagnostic body mass index, plasma C-peptide concentration, and prostate cancer-specific mortality among men with prostate cancerJournal Article2019-09-0610.1016/S1470-2045(08)70235-3